Key result
CHD prevalence in type 2 diabetes dropped ~8 percentage points from 2007 to 2016.
Why the study?
Cardiovascular diseases are the primary cause of death in patients with diabetes mellitus, warranting evaluation of CVD epidemiology and trends across implementation periods of the Federal Program.
Does the implementation of organized diabetes care programs reduce the prevalence and incidence of cardiovascular diseases in adult patients with diabetes mellitus?
Observational
Yes
Does the implementation of organized diabetes care programs reduce the prevalence and incidence of cardiovascular diseases in adult patients with diabetes mellitus?
The implementation of organized federal diabetes care and prevention programs is associated with a substantial long-term reduction in the prevalence of cardiovascular complications among patients with diabetes.
Answers are grounded in this paper and cite their sources.
Observed CHD prevalence decline in Russian T2DM patients may reflect care improvements; leaves open whether federal programs drove trends or confounders predominate.
BACKGROUND: Cardiovascular diseases (CVD) are the main cause of death for patients with diabetes mellitus (DM). AIMS: To evaluate the CVD epidemiology: coronary heart disease (CHD), myocardial infarction (MI) and cerebrovascular diseases in adult patients with type 1 (T1DM) and type 2 (T2DM) diabetes, compare dynamics with data of implementation of the Federal Program Diabetes mellitus in 20072012 and over the online period 20132016. MATERIALS AND METHODS: The database of the Federal Diabetes register (81 regions at 12.2017). We estimated prevalence and incidence rates/10 thousand (th) adult DM patients over 18 years. RESULTS: The prevalence of CVD for the period 2007 2016 significant decreased in CHD for T1DM from 14,9% to 3,5%, for T2DM from 20,1% to 11,7%; MI for T1DM from 5,7% to 1,3%, for T2DM from 7,6% to 3,5%; cerebrovascular diseases for T1DM from 4,9% to 1,7%, for T2DM from 7,6% to 4,3%, respectively. In 20132016 positive trends continued: MI for T1DM 8,25,9/10th patients, for T2DM 19,214,7/10th patients, respectively; CVD for T1DM 11,310,5, for T2DM 29,425,4/10th patients, respectively. There was a large heterogeneity of the prevalence of CVD in the regions. MI varied in patients for T1DM from 319/10 th patients to absence, for T2DM from 800 to 7/10 th patients; the development of cerebrovascular diseases for T2DM from 900 to less than 100/10 th patients, which is largely due to differences in their registration. A small number of cases may be due to insufficient filling of the database, the facts of a huge number require further analysis. The average age of development of MI had increased: for T1DM 51,253 years, for T2DM 63,565 years, cerebrovascular diseases for T1DM 52,352.5 years, for T2DM 65,266,5, respectively. CONCLUSIONS: The prevalence of CVD significantly decreased in the Russian Federation compared to 20072012, as well as for the period 20132016: the prevalence of CHD and cerebrovascular diseases declined, the number of new cases of MI decreased, the average age and duration of DM before the development of CVD significantly increased. These data reflect the results of the program for improvement medical care and prevention measures for patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Kalashnikov et al. (2019) conducted an observational in Type 1 and Type 2 Diabetes Mellitus. Time period 2013-2016 (following Federal Program implementation) vs. Historical period (2007-2012) was evaluated on Prevalence of coronary heart disease (CHD) in Type 2 Diabetes Mellitus. The prevalence of coronary heart disease among patients with type 2 diabetes in the Russian Federation decreased from 20.1% in 2007 to 11.7% in 2016.
Synapse has enriched 10 related papers. Consider them for comparative context: